NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Atomo Diagnostics Limited (AU: AT1)
AT1 Technical Analysis
5
As on 13th Oct 2025 AT1 STOCK Price closed @ 0.03 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.02 & Strong Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AT1STOCK Price
Open | 0.03 | Change | Price | % |
High | 0.03 | 1 Day | 0.01 | 50.00 |
Low | 0.02 | 1 Week | 0.00 | 0.00 |
Close | 0.03 | 1 Month | 0.01 | 50.00 |
Volume | 269803 | 1 Year | 0.00 | 0.00 |
52 Week High 0.03 | 52 Week Low 0.01 |
AU Australia Most Active Stocks
DTM | 0.01 | % |
IXR | 0.03 | % |
SGQ | 0.14 | 16.67% |
ARU | 0.36 | 20.00% |
EUR | 0.26 | 18.18% |
AVL | 0.01 | 0.00% |
OVT | 0.01 | 0.00% |
NVX | 0.81 | 5.19% |
EQR | 0.04 | 0.00% |
NTU | 0.05 | 25.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
AT1 Daily Charts |
AT1 Intraday Charts |
Whats New @ Bazaartrend |
AT1 Free Analysis |
|
AT1 Important Levels Intraday
RESISTANCE | 0.05 |
RESISTANCE | 0.04 |
RESISTANCE | 0.04 |
RESISTANCE | 0.04 |
SUPPORT | 0.02 |
SUPPORT | 0.02 |
SUPPORT | 0.02 |
SUPPORT | 0.01 |
AT1 Forecast October 2025
4th UP Forecast | 0.05 |
3rd UP Forecast | 0.04 |
2nd UP Forecast | 0.04 |
1st UP Forecast | 0.04 |
1st DOWN Forecast | 0.02 |
2nd DOWN Forecast | 0.02 |
3rd DOWN Forecast | 0.02 |
4th DOWN Forecast | 0.01 |
AT1 Weekly Forecast
4th UP Forecast | 0.03 |
3rd UP Forecast | 0.03 |
2nd UP Forecast | 0.03 |
1st UP Forecast | 0.03 |
1st DOWN Forecast | 0.03 |
2nd DOWN Forecast | 0.03 |
3rd DOWN Forecast | 0.03 |
4th DOWN Forecast | 0.03 |
AT1 Forecast2025
4th UP Forecast | 0.09 |
3rd UP Forecast | 0.07 |
2nd UP Forecast | 0.06 |
1st UP Forecast | 0.05 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | -0.01 |
4th DOWN Forecast | -0.03 |
Atomo Diagnostics Limited ( AU Australia Symbol : AT1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AT1 Other Details
Segment | EQ | |
Market Capital | 176265392.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
AT1 Address
![]() |
AT1 Latest News
AT1 Business Profile
Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing in Australia and internationally. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia. Address: 701-703 Parramatta Road, Leichhardt, NSW, Australia, 2040
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service